[{"address1": "Wagistrasse 14", "city": "Schlieren", "zip": "8952", "country": "Switzerland", "phone": "41 44 755 77 00", "fax": "41 44 755 77 07", "website": "https://www.molecularpartners.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Molecular Partners AG, a clinical-stage biotechnology company, develops designed ankyrin repeat proteins therapeutics for the treatment of oncology and virology diseases in Switzerland. The company develops MP0317, a CD40 agonist designed to activate immune cells within the tumor microenvironment by anchoring to fibroblast activation protein that is in Phase I clinical trial; and MP0533, a novel tetra-specific T cell-engaging DARPin for acute myeloid leukemia. It also develops Switch-DARPin platform, a multispecific cKIT x CD16a x CD47 Switch-DARPin program for targeted and conditional immune cell activation; and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. It has license and research collaboration agreements with Novartis Pharma AG to develop DARPin-conjugated radioligand therapies; and collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland.", "fullTimeEmployees": 161, "companyOfficers": [{"maxAge": 1, "name": "Dr. Patrick  Amstutz Ph.D.", "age": 48, "title": "Co-Founder, CEO, Member of Management Board & Director", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 786456, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael Tobias Stumpp Ph.D.", "age": 51, "title": "Co-Founder, Executive VP of Projects & Member of Management Board", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Hendriks", "title": "Senior VP of Finance", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alexander  Zurcher", "age": 48, "title": "COO & Member of Management Board", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Renate  Gloggner", "age": 53, "title": "Executive VP of People & Community and Member of Management Board", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Steiner Ph.D.", "title": "Senior Vice President of Research & Technology", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Seth D. Lewis", "title": "Senior Vice President of Investor Relations, Communications & Strategy", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Pitzner", "title": "General Counsel, Compliance Officer, Senior VP Legal & Business Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Pamela A. Trail Ph.D.", "age": 67, "title": "Strategic Consultant", "yearBorn": 1956, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Anne  Goubier D.V.M., Ph.D.", "title": "Senior Vice President of Research & Early Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 8.0, "open": 8.0, "dayLow": 8.0, "dayHigh": 10.14, "regularMarketPreviousClose": 8.0, "regularMarketOpen": 8.0, "regularMarketDayLow": 8.0, "regularMarketDayHigh": 10.14, "beta": 0.614, "volume": 300, "regularMarketVolume": 300, "averageVolume": 29, "bid": 4.3, "ask": 7.6, "bidSize": 21500, "askSize": 21500, "marketCap": 198357520, "fiftyTwoWeekLow": 3.4, "fiftyTwoWeekHigh": 10.14, "priceToSalesTrailing12Months": 25.229906, "fiftyDayAverage": 6.6828, "twoHundredDayAverage": 4.7799, "currency": "USD", "enterpriseValue": 39368436, "floatShares": 17320979, "sharesOutstanding": 33182600, "heldPercentInsiders": 0.09189, "heldPercentInstitutions": 0.42495, "bookValue": 4.688, "priceToBook": 1.2563993, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -57626000, "trailingEps": -2.06, "enterpriseToRevenue": 5.007, "enterpriseToEbitda": -0.645, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "MLLCF", "underlyingSymbol": "MLLCF", "shortName": "Molecular Partners AG", "longName": "Molecular Partners AG", "firstTradeDateEpochUtc": 1528983000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "992c585a-515b-3488-bb8f-5990e21df8b2", "gmtOffSetMilliseconds": -14400000, "currentPrice": 5.89, "recommendationKey": "none", "totalCash": 159126000, "totalCashPerShare": 4.795, "ebitda": -61049000, "totalDebt": 3049000, "quickRatio": 14.304, "currentRatio": 14.578, "totalRevenue": 7862000, "debtToEquity": 1.96, "revenuePerShare": 0.239, "returnOnAssets": -0.19312, "returnOnEquity": -0.31878, "freeCashflow": -38133000, "operatingCashflow": -61951000, "revenueGrowth": 2.737, "operatingMargins": -10.30045, "financialCurrency": "CHF", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]